AbCellera Biologics Inc. financial data

Symbol
ABCL on Nasdaq
Location
150 W 4 Th Avenue, Vancouver, British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.03K % +19.9%
Debt-to-equity 34.9 % +21.3%
Return On Equity -17 % -7.82%
Return On Assets -12.6 % -2.95%
Operating Margin -740 % +20.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 299M shares +1.34%
Common Stock, Shares, Outstanding 299M shares +2.82%
Entity Public Float 671M USD -54.2%
Common Stock, Value, Issued 794M USD +2.8%
Weighted Average Number of Shares Outstanding, Basic 299M shares +1.36%
Weighted Average Number of Shares Outstanding, Diluted 299M shares +1.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.3M USD +7.16%
Research and Development Expense 183M USD +7.66%
Selling and Marketing Expense 11.9M USD -6.56%
General and Administrative Expense 73.3M USD +0.84%
Operating Income (Loss) -261M USD +15.2%
Nonoperating Income (Expense) 56.4M USD -46.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -205M USD -1.36%
Income Tax Expense (Benefit) -33.2M USD -26.1%
Net Income (Loss) Attributable to Parent -172M USD +2.34%
Earnings Per Share, Basic 0 USD/shares +5%
Earnings Per Share, Diluted 0 USD/shares +5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.2M USD -34.3%
Cash, Cash Equivalents, and Short-term Investments 496M USD -22.9%
Other Assets, Current 133M USD +207%
Assets, Current 695M USD -6.43%
Property, Plant and Equipment, Net 277M USD +38.2%
Operating Lease, Right-of-Use Asset 138M USD +102%
Intangible Assets, Net (Excluding Goodwill) 39.3M USD -25.2%
Goodwill 47.8M USD 0%
Other Assets, Noncurrent 53.1M USD -60.5%
Assets 1.36B USD -2.65%
Employee-related Liabilities, Current 7.23M USD +20.7%
Contract with Customer, Liability, Current 15.7M USD +181%
Liabilities, Current 68.8M USD -13.5%
Contract with Customer, Liability, Noncurrent 5.85M USD -27.8%
Deferred Income Tax Liabilities, Net 9.74M USD -23.8%
Operating Lease, Liability, Noncurrent 137M USD +107%
Other Liabilities, Noncurrent 1.39M USD -9.06%
Liabilities 392M USD +24.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.7M USD -119%
Retained Earnings (Accumulated Deficit) -20.5M USD -114%
Stockholders' Equity Attributable to Parent 964M USD -10.6%
Liabilities and Equity 1.36B USD -2.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.6M USD +72.3%
Net Cash Provided by (Used in) Financing Activities 5.97M USD +111%
Net Cash Provided by (Used in) Investing Activities 7.94M USD -73.5%
Common Stock, Shares, Issued 299M shares +2.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.94M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108M USD -28.7%
Deferred Tax Assets, Valuation Allowance 49.9M USD +47.5%
Deferred Tax Assets, Gross 104M USD +27.5%
Operating Lease, Liability 65.4M USD -15.5%
Depreciation 15.4M USD +8.73%
Payments to Acquire Property, Plant, and Equipment 10.6M USD -55.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -173M USD +1.38%
Property, Plant and Equipment, Gross 304M USD +40.6%
Operating Lease, Liability, Current 5.17M USD +0.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.88M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.82M USD -20.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.78M USD -16.2%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD +115%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.82M USD -5.23%
Amortization of Intangible Assets 922K USD -45.4%
Share-based Payment Arrangement, Expense 58.1M USD -15.5%